title: Retinal pigment epithelial tear following ranibizumab use.
authors.forename: L
authors.initials: L
authors.lastname: Amselem
authors.forename: J S
authors.initials: JS
authors.lastname: Pulido
authors.forename: M
authors.initials: M
authors.lastname: Diaz-Llopis
authors.forename: E
authors.initials: E
authors.lastname: Cervera
authors.forename: J
authors.initials: J
authors.lastname: Montero
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D000069579:Ranibizumab; D012167:Retinal Perforations / Q000139:chemically induced*; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069579:Ranibizumab